Skip to main content

Refine your search


Agreement between FinELib and ACS not renewed

FinELib and American Chemical Society haven’t been able to reach an agreement in their negotiations. Access to ACS’s new journals has ended at the end of 2023.

FinELib and ACS have been negotiating for a new agreement throughout the autumn but haven’t been able to reach a mutual understanding. There are disagreements over agreement details that are significant for both users and consortium members. FinELib is aiming to continue the negotiations with ACS.

Read more about how the termination of the agreement will affect the reading and open access publishing on ACS journals in the FinELib news. Also check out FinELib's Alternative Access page, where you can find tips on alternative pathways to articles.